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Mammalian ZFY genes are located on the Y chromosome, and code putative transcription factors with 12–13
zinc ﬁngers preceded by a large acidic (activating) domain. In mice, there are two genes, Zfy1 and Zfy2, which
are expressed mainly in the testis. Their transcription increases in germ cells as they enter meiosis, both are
silenced by meiotic sex chromosome inactivation (MSCI) during pachytene, and Zfy2 is strongly reactivated
later in spermatids. Recently, we have shown that mouse Zfy2, but not Zfy1,i si n v o l v e di nt r i g g e r i n gt h e
apoptotic elimination of speciﬁc types of sex chromosomally aberrant spermatocytes. In humans, there is
a single widely transcribed ZFY gene, and there is no evidence for a speciﬁc role in the testis. Here, we char-
acterize ZFY transcription during spermatogenesis in mice and humans. In mice, we deﬁne a variety of Zfy
transcripts, among which is a Zfy2 transcript that predominates in spermatids, and a Zfy1 transcript, lacking
an exon encoding approximately half of the acidic domain, which predominates prior to MSCI. In humans, we
have identiﬁed a major testis-speciﬁc ZFY transcript that encodes a protein with the same short acidic
domain. This represents the ﬁrst evidence that ZFY has a conserved function during human spermatogen-
esis. We further show that, in contrast to the full acidic domain, the short domain does not activate transcrip-
tion in yeast, and we hypothesize that this explains the functional difference observed between Zfy1 and Zfy2
during mouse meiosis.
INTRODUCTION
In eutherian (placental) mammals, ZFY genes appear to play an
importantroleinmaledevelopment,astheyhavebeenfoundon
the Y chromosome in many species including humans and mice
(1). ZFY genes have a widely expressed X-linked homologue,
ZFX, that codes a highly similar protein; this has been shown
tobearegulatorofself-renewalinembryonicandhaematopoei-
tic stem cells (2). In metatherian (marsupial) mammals, genes
related to ZFX and ZFY are autosomal (3), and it is thought
that ZFX and ZFY originated more than 100 million years ago,
after the separation of eutherian and metatherian lineages, by
translocation of an autosomal segment to the pseudo-autosomal
region in a common ancestor of extant eutherians (4). ZFY and
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Advance Access published on March 9, 2012ZFX genes code putative transcription activators, characterized
byalargeN-terminalacidic(activating)domain(approximately
360 amino acids) and a C-terminal DNA-binding domain of
12–13 Cys2-His2 zinc ﬁngers, separated by a short basic
nuclear localization signal (5,6). The DNA targets and protein
partners of ZFY and ZFX remain to be determined.
There are two ZFY genes on the mouse Y chromosome, Zfy1
and Zfy2 (94% amino acid identity), both of which are tran-
scribed primarily in germ cells in the post-natal testis, but
have also been described in some fetal tissues (7–10). Post-
natal transcripts from the Zfy1 and Zfy2 genes are ﬁrst
readily detected in the testis around the time that the germ
cells enter meiosis, between 7 and 10 d.p.p. (days postpartum)
(9,11). RNA FISH (ﬂuorescence in situ hybridization) detect-
ing ongoing transcription has documented the transcriptional
silencing of Zfy1 and Zfy2 as they enter pachytene, a manifest-
ation of meiotic sex chromosome inactivation (MSCI), and has
identiﬁed Zfy2 transcription in Y-bearing round spermatids
(12–14). Reﬂecting this resumption of Zfy2 transcription in
spermatids, Zfy2 transcript levels have been observed to in-
crease between 22 and 24 d.p.p. as spermatids appear and
develop (11). Strong Zfy2 transcription in spermatids is direc-
ted by an ‘acquired’ spermatid-speciﬁc promoter derived from
an X-linked CYPT gene (11). The CYPT genes form a
spermatid-speciﬁc gene family (15). The CYPT exon of Zfy2
is most likely derived from Cypt1, as it is ﬂanked by
12.1 kb of a sequence (5′: 7.8 kb; 3′: 4.3 kb) with approxi-
mately 90% nucleotide identity to the genomic region sur-
rounding Cypt1 (Genome assembly NCBI37—chrX:
16087265–16107151). Zfy1 does not have an upstream copy
of the CYPT promoter, and the presence of Zfy1 transcripts
in spermatids remains to be determined. Furthermore, the
nature of the promoter used by Zfy2 for its early expression
and the structure of the Zfy1 and Zfy2 transcripts produced
at the different stages of spermatogenesis have not been deter-
mined.
In mice, the Zfy genes are affected by the  1.3 Mb Sxr
b de-
letion that occurred in the mouse Y short-arm-derived ‘sex-
reversal factor’ Tp(Y)1Ct
Sxr2a (16) via an illegitimate recom-
bination between the Zfy1 and Zfy2 genes; this created a tran-
scribed Zfy2/1 fusion gene composed of the promoter region,
5′ UTR (untranslated region) and ﬁrst coding exon of Zfy2
fused in intron 5 to the remaining six coding exons of Zfy1
(17). This effectively puts the Zfy1 coding region under the
control of the Zfy2 promoter (18). For this reason, it has
been difﬁcult to assess how ZFY function has been affected
by the deletion, if at all. Recently, however, we have shown
that ZFY is involved in the apoptotic elimination of spermato-
cytes in two types of sex chromosomally variant males. First,
we have shown that in XYY males the apoptotic elimination of
spermatocytes during the mid pachytene stage is due to the
mis-expression of Zfy1 and Zfy2; both genes are silenced
during pachytene in normal males but escape silencing when
the two Y chromosomes are synapsed (13). Second, Zfy2
(but not Zfy1 or the Zfy2/1 fusion gene) has been shown to
be required for the efﬁcient apoptotic elimination of spermato-
cytes at the ﬁrst meiotic metaphase (MI) that occurs in re-
sponse to the X univalent in XSxr
aO males that carry the
sex reversal factor Tp(Y)1Ct
Sxr2a attached to the pseudoauto-
somal regions (PAR) of the X chromosome (18).
In humans, in contrast to mice, there is a single ZFY gene on
the Y chromosome; furthermore, the transcription of human
ZFY is ubiquitous (1). Despite its widespread expression, a
rare deletion of ZFY and SRY in a woman carrying a Y;22
balanced translocation was not associated with Turner syn-
drome stigmata, indicating that ZFY has no critical somatic
functions (19). No mutations of ZFY have been described in
men and there is, therefore, no information concerning its pos-
sible contribution to human germ cell development or male
fertility.
With the aim of understanding the basis of the functional
difference observed between the nearly identical Zfy1 and
Zfy2 genes in relation to the apoptotic response to X chromo-
some univalence at MI, we undertook a detailed analysis of
mouse Zfy transcription during spermatogenesis. We reveal
an unexpected complexity of Zfy transcription involving mul-
tiple splice variants. This led us to reassess ZFY transcripts in
the human testis where we have identiﬁed a testis-speciﬁc
splice-variant, structurally homologous to the major Zfy1
variant transcript in mice.
RESULTS
Zfy1 and Zfy2 are transcribed in early spermatocytes and
round spermatids
In order to deﬁne the cell types in which the Zfy1 and Zfy2
genes are transcribed in the adult testis, we carried out RNA
FISH designed to identify nascent transcripts within the
nucleus as they are transcribed (20) (Fig. 1). No clear hybrid-
ization was seen in nuclei of Sertoli cells or other somatic
cells. Weak hybridization signals were seen in nuclei of a
few A spermatogonia (Zfy1: 1/20, and Zfy2: 2/30; data not
shown), but appropriate localization to the encoding genes
was not conﬁrmed by DNA FISH; no Zfy signals were
detected in B or intermediate spermatogonia. Zfy1 and Zfy2
signals then began to appear during leptotene (data not
shown), and robust signals were clearly present in all
mid-late zygotene nuclei. As expected, no signals were
detected in pachytene nuclei where the Zfy genes are silenced
by MSCI. In agreement with previous data, Zfy2 transcription
is resumed in (Y-bearing) round spermatids where it localizes
to the post meiotic sex chromatin; however, Zfy1 is also
clearly transcribed at this stage, although it was detected in
a substantially lower proportion of spermatid nuclei than
Zfy2 (17.5 versus 37%, which equates to 35 versus 74% of
Y-bearing spermatids). The higher proportion of spermatids
with a Zfy2 signal probably reﬂects the higher level of Zfy2
transcription from the strong Cypt-promoter in spermatids.
Our results establish that both Zfy1 and Zfy2 genes are tran-
scribed in spermatocytes prior to the onset of MSCI, and
that both genes are reactivated in spermatids.
5′ UTRs and putative promoters of mouse Zfy genes
We analysed the Zfy1 and Zfy2 transcripts produced during
spermatogenesis, using qualitative and quantitative reverse
transcriptase polymerase chain reaction (RT-PCR) with
RNAs extracted from testes at different ages after birth: 3
and 7 d.p.p. (spermatogonia only), 10, 16 and 20 d.p.p.
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(spermatogonia + spermatocytes + spermatids). Zfy exons are
numbered following the published genomic structure of Zfy1
and Zfy2 (21), which are shown in Figure 2A.
We ﬁrst investigated the use of the different putative promo-
ters by amplifying from the ﬁrst exons of Zfy1 (exon 1b) or
Zfy2 (exon 1a or 1b) to exon 5, the ﬁrst coding exon
(Fig. 2B). The identiﬁcation of transcripts at 7 d.p.p. provides
some support for the RNA FISH identiﬁcation of weak Zfy1
and Zfy2 signals in some A spermatogonia. The products iden-
tiﬁed at 7 and 16 d.p.p. show that during early meiotic stages
prior to the onset of MSCI, Zfy1 and Zfy2 transcripts include
exon 1b (transcripts Zfy1-b and Zfy2-b). We show that Zfy2
does not, however, use the alternative non-coding exons 3 or
4, as previously described for Zfy1 (7). There is no evidence
that any one 5′ UTR structure of Zfy1 is speciﬁc to a particular
stage of spermatogenesis. As shown previously (11), the Zfy2
transcripts with exon 1a (Zfy2-a), produced from the
spermatid-speciﬁc Cypt-promoter, are not detected at earlier
stages, appearing only in the testis containing spermatids (27
and 50 d.p.p.).
These results were conﬁrmed and extended by quantitative
PCR (qPCR) (Fig. 2C). Zfy1-b transcripts were ampliﬁed
with primers in exons 8 and 10, to avoid the multiple bands
generated by PCR from exon 1b for Zfy1. As expected,
levels of Zfy2-a( Cypt) were strong only in the testis with sper-
matids (27 and 50 d.p.p.). However, Zfy1-b and Zfy2-b are
seen to increase between 7 and 20 d.p.p. as spermatocytes
appear and develop. Zfy1-b levels continue to increase with
the arrival of spermatids (27 d.p.p.), consistent with our
RNA FISH data showing that Zfy1 is reactivated in spermatids.
For Zfy2-b, however, levels remain constant between 16 and
50 d.p.p., suggesting that the Zfy-promoter of Zfy2 is not as
strongly reactivated in spermatids as that of Zfy1.
The two Zfy genes in the mouse are generally held to differ in
their 5′ UTRs, and to be transcribed from distinct promoters,
with Zfy2 assumed to be transcribed exclusively from a
Cypt-promoter, even though Zfy2 retains sequences nearly iden-
tical to the 5′ UTR and putative promoter of Zfy1 (11,21,22).
Here,weshow,however,thatZfy2doesuseitsZfy1-homologous
promoter, and 5′ UTR, in particular for its earlier phase of post-
natal transcription, when the Cypt-promoter is silent.
Figure 1. The mouse Zfy genes are transcribed in early spermatocytes and spermatids. Representative images of germ cells are shown hybridized with probes
speciﬁc for Zfy1 or Zfy2 (green). Zygotene and pachytene spermatocytes were identiﬁed by staining with an antibody against gH2AX (red). Nuclei are stained
with DAPI (blue). The speciﬁcity of the probes for each gene is shown with control zygotene spermatocytes from testis of 30 d.p.p. transgenic males without a Y
chromosome but carrying Zfy1 (X
EZ1/UOSry)o rZfy2 (X
EZ2OSry) as a transgene (germ cells develop to secondary spermatocytes in these mice). The numbers of
germ cells (zygotene, pachytene or spermatid) scored as positive or negative for Zfy1 and Zfy2 transcription in adult are presented in the table, for the wild-type
(XY) adult testis. No signiﬁcant labelling of Zfy transcripts was observed for any other testicular cell types. The double signal observed for Zfy2 in spermatids
probably reﬂects the high level of Zfy2 transcription from the Cypt promoter in spermatids, since the number of RNA FISH signals per spermatid has been found
to increase with transcript levels (44).
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To investigate coding exon usage for Zfy1 and Zfy2, we per-
formed RT-PCR, on testis RNA from normal XY males,
with primers in the ﬁrst and last coding exons (Fig. 3A). Un-
expectedly, the major product for Zfy1 was  500 bp smaller
than predicted. The expected size was observed for Zfy2. Se-
quencing revealed the major pre-MSCI Zfy1 product
(16 d.p.p.) to have spliced out exon 6, a 552 bp exon that
codes for half the acidic domain. Sequencing the major
product for Zfy2 revealed it to include the full exon 6. The
lower of the two strongest minor Zfy2 products at  900 bp
lacks exon 6, whereas the upper product is a doublet that
retains 111 or 123 bp of exon 6 (Fig. 3B).
We then zoomed in on this region, using Zfy1-o rZfy2-
speciﬁc primers in exon 5 and 7, and conﬁrmed that Zfy1
transcripts predominantly lack exon 6, whereas the major
Zfy2 transcripts retain exon 6. This is especially evident at
16 d.p.p. (Fig. 3B). We performed qPCR analysis with
primer pairs speciﬁc for the splice variants with or without
exon 6 and speciﬁc for Zfy1 or Zfy2 (Fig. 3C). This revealed
that, for Zfy1, the transcript with exon 6 is present at low
levels until 20 d.p.p., but increases more than 4-fold
between 20 and 27 d.p.p., coincident with the progression
of germ cells into spermiogenesis. On the contrary, the
concentration of Zfy1 transcript without exon 6 reaches its
peak between 16 and 20 d.p.p. prior to the development of
spermatids. For Zfy2, the transcript with exon 6 increases
between 10 and 20 d.p.p., as spermatocytes accumulate,
and further increases between 20 and 27 d.p.p., when the
strong Cypt promoter becomes active. The Zfy2 transcript
without exon 6 can be seen to increase between 20 and
27 d.p.p., but is expressed at extremely low levels at 7–
20 d.p.p., when meiotic stages appear and develop in the
testis.
These results show that, in spermatocytes, prior to the onset
of MSCI, Zfy transcription is strongly characterized by the dif-
ferential splicing of exon 6 that is predicted to generate two
ZFY protein isoforms with very different acidic domains.
The quantitative real-time reverse transcription PCR
Figure 2. Zfy2 uses an early (pre-MSCI) and a late (spermatid) promoter during mouse spermatogenesis. (A) The genomic structure of the mouse Zfy1 and Zfy2
genes. Exons are represented by boxes: coding exons are shaded and non-coding are white. Introns and exons are not to scale. (B) RT-PCR analysis of mRNA
from wild-type mouse testis of 7, 16, 27 and 50 d.p.p. with primers in exon 1 and exon 5 of the different Zfy transcripts: exon 1b for Zfy1 and exon 1a or exon 1b
for Zfy2. For the negative controls (neg), Milli-Q water replaced cDNA. The structure of ampliﬁed fragments is shown and was determined by sequencing. L ¼
1 kb plus DNA size ladder (Invitrogen), and sizes of some ladder bands are indicated in base pairs (bp). (C) Quantitative RT-PCR analysis of Zfy1 transcripts and
the two Zfy2 transcripts from the Cypt- or the Zfy-promoter, in staged testes. The error bars represent the standard deviation of triplicates. Oligonucleotides used
for PCRs are indicated as a number preﬁxed with an ‘o’, and are listed in Supplementary Material, Table S1.
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scripts with exon 6 increases in spermatids, suggesting that the
predominance of Zfy1 transcripts without exon 6 may be spe-
ciﬁc to spermatocytes.
Polyadenylation site usage of mouse Zfy transcripts
We also found gene- and stage-speciﬁc differences in polyade-
nylation (polyA) site usage by 3′ RACE (Fig. 4A). Sequencing
the major 3′ RACE products showed that Zfy1 uses two polyA
sites, one major (3′ UTR: 196 bp) and the other minor (3′
UTR: 124 bp). The major site is 14 bp downstream of a canon-
ical AATAAA motif. The minor site is 15 bp after a non-
canonical AATATAAA site.
Zfy2 also uses two polyA sites. However, a comparison of
the 3′ UTRs from Zfy1 with those of Zfy2 reveals that the ca-
nonical AATAAA polyA signal used by Zfy1 is absent from
Zfy2. Instead Zfy2 uses an upstream site corresponding to
the minor Zfy1 site (3′ UTR: 124 bp) for its late transcripts
(mostly Cypt transcripts) in spermatids, and a downstream
site (3′ UTR: ≥284 bp) for its pre-MSCI transcripts, giving
it a 3′ UTR that is longer than Zfy1 at the early stage. The
major downstream site used by Zfy2 is difﬁcult to deﬁne
because the major Zfy2 3′ RACE product, at 16 d.p.p., has
its 3′ end within a genomic polyadenosine tract (dA14)
(Fig. 4A). The true polyA site of the Zfy2 meiotic transcript
must, therefore, be situated further downstream.
Conventional PCR from exon 5 to a primer speciﬁc for each
3′ UTR in exon 11 of Zfy1 or Zfy2 ampliﬁed fragments with
and without exon 6, showing that the inclusion or exclusion
of exon 6 is not associated with a particular 3′ UTR for
either Zfy1 or Zfy2 (Fig. 4B and C). RT-qPCR shows that
the levels of Zfy1 transcripts with the shorter 3′ UTR increase
between 16 and 27 d.p.p., whereas the levels of the medium 3′
UTR increase between 7 and 16 d.p.p. and then remain con-
stant (Fig. 4B). This is also indicated by the 3′ RACE result
for Zfy1 (Fig. 4A), where the short product, at 27 and
50 d.p.p., appears stronger, relative to the medium product,
than it does at 7 and 16 d.p.p.. This suggests that the usage
of the minor polyA site may increase in spermatids for Zfy1,
as is observed for Zfy2.
Although human ZFY also uses alternative polyA sites and
the non-canonical AATATAAA site (23), only a short stretch
of nucleotide homology remains between the mouse and
human 3′ UTR (61 bp with 79% nucleotide identity), begin-
ning, respectively, at 23 and 24 bp after the stop codon. This
Figure 3. Zfy1 and Zfy2 produce major gene-speciﬁc transcripts coding distinct putative activating domains during mouse spermatogenesis. (A) RT-PCR of
mRNA from staged testes of wild-type mice with primer pairs speciﬁc for Zfy1 or Zfy2 in the ﬁrst and the last coding exons (exon 5 and exon 11). Ampliﬁed
fragments were sequenced, and the structure of the ampliﬁed fragments are shown. For Zfy2, the major product (arrow) is at  1400 bp, and its sequence shows it
to have the same complete structure as the published cDNA sequences of Zfy1 and Zfy2. In contrast, for Zfy1, the major product (arrowhead) is  850 bp and does
not include the 552 bp coding exon 6. The minor product at 950 bp for Zfy2 includes the last 111 or 123 bp of exon 6. The Zfy2 transcript without exon 6 becomes
clearly visible but remains minor at 27 d.p.p. when spermatids are present. White arrow: transcripts with exon 6. White arrowhead: transcripts without exon
6. (B) RT-PCR analysis of wild-type mouse testes with primer pairs speciﬁc for Zfy1 or Zfy2 in exon 5 and exon 7. The exon structures of the products ampliﬁed
were determined by sequencing and are shown to the right of the graphic representation of the electrophoresed PCR products. (C) RT-qPCR analysis was per-
formed with primers speciﬁc for the Zfy1 or Zfy2 transcripts with or without exon 6 in staged wild-type mouse testes. These results show a complementary pattern
of transcription for the Zfy genes; up to 20 d.p.p., Zfy2 produces the transcript with exon 6, whereas Zfy1 mainly produces the transcript without exon 6. There is
an increase of both Zfy1 and Zfy2 transcripts including exon 6 between 20 and 27 d.p.p. when spermatids ﬁrst develop in the testis. For RT-qPCR, Ct values were
normalized to the Hmbs reference gene. The error bars represent the standard deviation of triplicates. L ¼ 1 kb plus DNA size ladder (Invitrogen), and sizes of
some ladder bands are indicated in base pairs (bp).
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fore, no strong evidence that ZFY polyA choice is achieved by
a conserved mechanism.
The Sxr
b deletion breakpoints within the Zfy2/1 fusion gene
The Sxr
b deletion is known to have arisen by unequal ex-
change between intron 5 of Zfy1 (20 705 bp) and intron 5 of
Zfy2 (11556 bp) (17). The exact breakpoints, resulting in the
generation of the Zfy2/1 fusion gene, have not been deter-
mined. Since the breakpoints map to the intron that precedes
the alternatively spliced exon 6, we localized the breakpoints
precisely using Zfy1- and Zfy2-speciﬁc STS markers from
intron 5 (data not shown), and then ampliﬁed and sequenced
the Sxr
b junction fragment (Fig. 5A and B). This revealed
that the Sxr
b deletion occurred by an illegitimate cross-over
event between Zfy1 and Zfy2 in 95 bp of identity. Based on
the position of the breakpoints on the mouse Y chromosome
contig NT_078925, we estimate the length of the Sxr
b deletion
interval to be 1 299 537 bp.
The Sxr
b junction fragment was conﬁrmed using a PCR
RFLP assay (Fig. 5C). This generated a speciﬁc RsaI fragment
only when the Sxr
b interval was present. This will be a useful
screening tool for the Sxr
b interval in general, and especially
for the identiﬁcation of XYSxr
b carrier males, previously iden-
tiﬁed through extensive breeding tests.
Zfy2/1 fusion gene transcripts in Sxr
b carrier mice
To better deﬁne the consequences of the Sxr
b deletion for Zfy
expression, we used RT-PCR to analyse the early and late
transcripts expressed from the Zfy2/1 fusion gene, in
X
ESxr
bO( Zfy2/1 only) and XYSxr
b (Zfy1, Zfy2 and Zfy2/1)
mice, in particular with reference to the presence or absence
of exon 6. XYSxr
b mice have full spermatogenesis, whereas
in X
ESxr
bO mice, interphasic secondary spermatocytes block
prior to the second meiotic division (18,24). The block in
X
ESxr
bO mice is leaky, however, and between 30 and
60 d.p.p. abnormal sperm appear in testis tubules (24).
Using a Zfy2-speciﬁc primer for exon 5 and a Zfy1-speciﬁc
primer from exon 10, we speciﬁcally ampliﬁed the Zfy2/1
fusion gene from XYSxr
b and X
ESxr
bO testes at early (10–
21 d.p.p.) and late (27–73 d.p.p.) stages (Fig. 6A and B).
We detected Zfy2/1 transcripts at both these stages, in Sxr
b
mice, but not in normal XY males. At early stages, the tran-
script without exon 6 predominates, showing that the fusion
gene is spliced like Zfy1, in spermatocytes. The similarity of
the Zfy2/1 and Zfy1 proﬁles at later stages suggests that this
is also the case in spermatids.
Figure 4. The Zfy genes use gene- and stage-speciﬁc polyA signals. (A)3 ′ RACE using nested primers in exon 11 of Zfy1 or Zfy2, with cDNA from staged testes
of wild-type mice. The major RACE products were sequenced and their structure is represented to the right of the gel. dA14 refers to the poly adenosine stretch
present in genomic DNA. nt, nucleotides. (B) RT-PCR and RT-qPCR analysis of Zfy1 transcripts with the short and medium 3′ UTR in staged wild-type mouse
testes. RT-PCR from exons 5–11 shows that the expression of the transcript with exon 6 increases between 16 and 27 d.p.p., a further indication that the full Zfy1
transcript increases in spermatids (Fig. 3B and C). The splicing of exon 6 appears to be independent of the 3′ UTR. The error bars represent the standard deviation
of triplicates. (C) RT-PCR analysis of Zfy2 transcripts with the long or short 3′ UTR in staged testes. The long 3′ UTR is used at pre-MSCI stages, since it is
ampliﬁed from 16 d.p.p. testis, containing only spermatogonia and spermatocytes. The short 3′ UTR is detectable only in testis with spermatids (27 and
50 d.p.p.), suggesting that it is speciﬁc to this later stage. The positive control RT-PCR is with Hmbs. PCR products with exon 6 (arrow) and without exon
6 (arrowhead) are indicated. L ¼ 1 kb plus DNA size ladder (Invitrogen), and sizes of some bands are indicated in base pairs (bp).
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ESxr
bO
testes with primers in exon 1a or 1b and exon 5 shows the
fusion gene to be transcribed from both Zfy2 promoters
(Fig. 6B). Transcripts with exon 1a (Cypt) are not detected
at early stages (Fig. 6B and C). This is the transcript that
was originally detected in adult XYSxr
b mice, using primers
in exon 1a and exon 6, when the Sxr
b deletion mechanism
was ﬁrst described (17). It is noteworthy that Cypt promoter-
driven transcripts are readily detected in 30 d.p.p. testis from
X
ESxr
bO males (Fig. 6B), because spermatids are not observed
by histological examination of X
ESxr
bO testis at this stage
(18,24). This is, therefore, an indication that, in X
ESxr
bO
mice, certain spermiogenic processes required for the activa-
tion of the spermatid-speciﬁc Cypt promoter continue inde-
pendently of the secondary spermatocyte block.
In XYSxr
b males, the presence of the Zfy2/1 fusion gene pro-
videsanopportunitytoinvestigatehowexon6ofZfy1isspliced
in spermatids. Using primers speciﬁc for exon 1a of Zfy2 and
exon 8 of Zfy1, Zfy2/1 fusion gene transcripts were ampliﬁed
with and without exon 6 (Fig. 6C), showing that the splicing
outofexon6doesoccurinspermatidsaswellasspermatocytes.
The 3′ RACE analysis (Fig. 6D) shows that the Zfy2/1
fusion gene transcripts predominately use the canonical
AATAAA polyA signal, and not the upstream AATATAAA
signal used by Zfy2 in spermatids.
In conclusion, we show that, besides the loss of the Zfy2
coding region, one of the principal consequences of the Sxr
b
deletion for the combined expression of the Zfy genes, is a
reduced level of transcripts coding the full-length Zfy acidic
domain, in spermatocytes and spermatids.
A testis-speciﬁc human ZFY transcript coding a short
acidic domain
There is a single widely expressed ZFY gene in human sug-
gesting that ZFY regulation may vary greatly between
humans and mice. We nevertheless investigated the splicing
of human ZFY in human testis. In human ZFY, it is exon 3
that corresponds to exon 6 in mouse Zfy1. Using RT-PCR
with primers in exon 2 and exon 4, we identiﬁed a transcript
lacking exon 3, present in the testis but not in the other
tissues tested (Fig. 7A). As in the mouse, exon 3 is the
second coding exon. It is 573 bp in length and codes for
around half of the putative activating domain of ZFY.
Testis-speciﬁc ZFY transcript in men with meiotic
maturation arrest
To investigate the possibility that, like its mouse counterpart,
the ZFY transcript lacking the second coding exon (exon 3) is
expressed in germ cells as they enter meiosis, we tested for its
expression in a testicular biopsy from two azoospermic men
with a histologically determined meiotic maturation arrest.
One, Ste-363, with a deletion of the AZFb interval of the Y
chromosome, has a pachytene block, whereas the other,
Apop12, with no detectable Y chromosome deletion has an
earlier block at the leptotene/zygotene transition. Expression
of the ZFY transcripts with and without exon 3 was tested
by RT-PCR with primers in exon 2 and exon 4. Transcripts
known to be speciﬁc to spermatids (PRM1 and TNP1) were
also tested to conﬁrm the absence of post-meiotic germ
cells, and the HPRT gene was tested as a positive control.
RT-PCR analysis showed the presence of ZFY transcripts
with and, importantly, without exon 3, in the absence of the
spermatid markers PRM1 or TNP1 (Fig. 7B). These results
provide evidence that, like Zfy1 in mice, ZFY in humans pro-
duces a transcript in germ cells prior to the onset of MSCI that
lacks the 573 bases of exon 3 (mouse exon 6).
ZFY transcripts present in human spermatids
We characterized indirectly the ZFY transcripts present in
human spermatids by the analysis of RNA extracted from puri-
ﬁed spermatozoa. During spermiogenesis, transcription ceases
Figure 5. Deﬁnition of the Sxr
b deletion interval breakpoint. (A) The deletion breakpoint was ﬁne-mapped within intron 5, using STS markers (data not shown).
The junction fragment was PCR-ampliﬁed with the primer pair o3452/o3072 and sequenced, localizing the Sxr
b deletion breakpoints to 95 bp of nucleotide
identity between Zfy1 and Zfy2.( B) Sequence of the Sxr
b breakpoint region (bold) within the Zfy2/1 fusion gene. Twenty bases of the ﬂanking sequences
are aligned to Zfy1 and Zfy2, and asterisks indicate the position of mismatches. (C) PCR-RFLP test to detect the Sxr
b junction fragment. Zfy1 and the Zfy2/1
fusion genes are ampliﬁed from genomic DNA with o3452 (Zfy1 + Zfy2) and o3072 (Zfy1), followed by digestion with RsaI, generating a 224 bp Sxr
b-speciﬁc
fragment.
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begin to elongate. A proportion of mRNAs already present in
spermatids are nevertheless retained in the mature spermato-
zoa, representing a sampling of the spermatid transcriptome
(25). We tested for ZFY transcripts by RT-PCR with primer
combinations speciﬁc for transcripts with or without exon 3
(Fig. 7C), and detected both transcripts in spermatozoa
RNA. However, compared with the whole testis, where the
product from the transcript with exon 3 is the stronger, it is
the product from the transcript without exon 3 that
Figure 6. Expression of the Zfy2/1 fusion gene created by the Sxr
b deletion in XYSxr
b carriers and X
ESxr
bO male mice. (A) RT-PCR analysis of staged testes
from XYSxr
b and XY males (same-stage littermates). Exon 6 of the Zfy2/1 fusion gene is spliced like Zfy1 and not like Zfy2.( B) RT-PCR analysis of staged testis
from X
ESxr
bO and XY males. X
ESxr
bO males carry the deleted Sxr
b region and an Eif2s3y transgene on the X chromosome (X
ESxr
b), and lack a Y chromosome
(O). In X
ESxr
bO testis, the Zfy2/1 fusion gene produces transcripts with exon 1a and exon 1b, showing it to be transcribed from both Zfy2 promoters, but exon 6 is
spliced as for Zfy1. The Usp9y gene, mapping to the Sxr
b deletion interval, was included as a negative control. Eif2s3y and Hmbs are positive controls. (C)
RT-PCR analysis of Cypt promoter-driven transcripts in staged testes from XYSxr
b males with same-stage XY littermates, and from X
ESxr
bO males, using
primers from exons 1a and 8. A substantial proportion of the Zfy2/1 fusion gene products lack exon 6, an indication that the splicing out of exon 6 is not exclusive
to spermatocytes, but also occurs in spermatids. (D)3 ′ RACE analysis of Zfy2/1 and Zfy1 transcripts. As for Zfy1, the medium 3′ UTR predominates. The band at
270 bp (asterisk) was sequenced and shown to be the result of priming from contaminating genomic DNA at a poly A tract situated 3′ of Zfy1. nt, nucleotides.
The positive control RT-PCR is with Hmbs. PCR products with exon 6 (arrow) and without exon 6 (arrowhead) are indicated. L ¼ 1 kb plus DNA size ladder
(Invitrogen), and sizes of some bands are indicated in base pairs (bp).
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without exon 3 is a major ZFY transcript in spermatids.
The short acidic domain of the ZFY protein does not
activate transcription
To investigate the functional differences between the two iso-
forms of the ZFY genes in mice and humans, we exploited the
fact that the acidic domains of Zfy2 and Zfx have been shown
to activate transcription in the yeast Saccharomyces cerevisiae
when fused to the DNA-binding domain of the Gal4 transcrip-
tional activator (5). We, therefore, generated six constructs
expressing the long or the short acidic domains of mouse
ZFY1, mouse ZFY2 and human ZFY fused to the Gal4 DNA-
binding domain in the vector pGBKT7 (Clontech). We also
generated a construct with the yeast Gal4 acidic domain
fused to the Gal4 DNA-binding domain as a positive
control, and the Gal4 DNA-binding domain alone (empty
vector) as a negative control. These constructs were trans-
formed into the Y187 strain of yeast containing a LacZ
(b-galactosidase) gene under the control of the Gal4-
dependent GAL1 promoter, and we estimated transcriptional
activation by measuring b-galactosidase activity.
Our resultswithtwoindependenttransformantsforeachcon-
struct show a clear difference between the long and the short
acidic domains (Fig. 8): whereas the long acidic domain
encoded by ZFY, Zfy2 and Zfy1 activated b-galactosidase pro-
duction like the acidic domain of Gal4, none of the three
short acidic domains activated at all. We were able to conﬁrm
the expression of all the ZFY-Gal4 fusion proteins by western
blot analysis, although ZFY2-long was extremely faint
(Supplementary Material, Fig. S1) and the Gal4-AD fusion
protein was not detected at all. We suspect that this may be
the result of selection against high expressing clones, since
it was the ZFY2-long and Gal4-AD fusion constructs that
induced the highest b-galactosidase activity, and these yeast
transformants alone gave very small colonies and grew very
slowly in liquid culture.
DISCUSSION
ZFY was isolated from the human Y chromosome, over 20
years ago, and was the ﬁrst gene to be found conserved on
the mouse and human Y chromosome (1,8). Most of the
early characterization of the two mouse Zfy genes focused
on their embryonic expression in the developing gonad
(7,9,26), with the aim of testing the hypothesis that ZFY was
the primary testis determinant (1). With the discovery that
testis determination was performed by SRY, in mice and
Figure 7. Human ZFY produces a major transcript without the second coding exon in the adult testis. (A) RT-PCR analysis of ZFY transcripts in human tissues.
Primers were derived from exons 2 and 4. Exon 3 of human ZFY is homologous to exon 6 of the mouse Zfy1 gene. A product lacking exon 3 was ampliﬁed from
the testis only, indicating that the ZFY transcript without exon 6 is transcribed in the human testis. (B) RT-PCR analysis of total RNA extracted from testicular
biopsies of patients, Ste-363 and Apop12, with a meiotic maturation arrest. Ste-363 has an AZFb deletion and the arrest is during pachytene. Apop12 does not
have an AZF deletion and 97% of the spermatocytes are at leptotene/zygotene transition. The ZFY transcript without exon 3 is ampliﬁed from the testis with a
spermatocyte-stage block. The absence of post-meiotic stages was controlled for by the failure to amplify spliced transcripts from PRM1 (protamine 1) and TNP1
(transition protein 1). The negative control sample (neg) was Milli-Q water. (C) RT-PCR analysis of RNA extracted from puriﬁed human spermatozoa. Tran-
scripts with and without exon 6 were ampliﬁed from spermatozoa RNA, showing that they are both present in spermatids. Primers derived from exon 2 and exon
4 were used to detect the transcripts with or without exon 3, and primers derived from exon 3 and exon 4 were used to detect the transcripts with exon 3 only.
HPRT and PRM1 served as positive control PCRs, KIT as a negative control PCR. L ¼ 1 kb plus DNA size ladder (Invitrogen), and sizes of some bands are
indicated in base pairs (bp).
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post-natal transcription of Zfy1 and Zfy2 has not been fully
explored.
Our study builds on this previous work to reveal unsuspect-
ed intricacies in Zfy transcription during mouse spermatogen-
esis in XY males and in males carrying the Sxr
b deletion. Our
study is the ﬁrst detailed analysis of Zfy transcripts during the
early phase of its expression prior to the onset of MSCI
(pre-MSCI).
A splice variant speciﬁc to ZFY genes in humans and mice
The principal ﬁnding of our study is that mouse Zfy1 and
human ZFY produce a previously unknown major splice
variant in the testis that results in the exclusion of the large
second coding exon (exon 6 in Zfy1) that represents a
quarter of the full-length ZFY protein and a half of the
acidic domain. This splice variant has not been found among
ZFX transcripts, including ESTs, in mice or humans (6,29).
Only one ZFX transcript without the second coding exon has
been identiﬁed, but it is from a human lymphoblastoid cell
line, and its splicing is different from the short ZFY transcripts
since the ﬁrst coding exon is also spliced out (6). For the
mouse, our own RT-PCR analyses (data not shown) with
primers speciﬁc for the ﬁrst and last coding exons of Zfx con-
ﬁrmed this, showing that the transcript encoding the full ZFX
acidic domain predominates in the testis. A secondary Zfx
transcript was detected that lacks the 150 nucleotide third
coding exon. This latter transcript certainly gave rise to the
Zfa retrogene which lacks the same exon. The production of
the short acidic domain through the splicing out of the large
second coding exon would, therefore, appear to be an adapta-
tion that is essentially speciﬁc to ZFY transcripts in the testis.
Functional consequences of the short acidic domain
Based on their structure, and the fact that the acidic domains
of mouse ZFY2 and ZFX have been shown to activate tran-
scription in yeast (5), ZFY proteins are predicted to bind to
speciﬁc sites in the genome via their zinc ﬁnger domain and
subsequently recruit regulatory or transcriptional machinery
through interactions with their negatively charged acidic
domain. We have now shown that, as for ZFY2, the long
acidic domain of mouse ZFY1 and human ZFY can activate
transcription at Gal4-responsive promoters in yeast. Import-
antly, however, we show that the short acidic domain from
ZFY1, ZFY2 or human ZFY does not activate transcription
in yeast.
In yeast, Gal4 is known to activate transcription through the
recruitment of a large pre-initiation complex including histone
acetyltransferases (HAT) and the TATA-binding protein to the
promoter region of target genes, with recruitment dependent on
a direct interaction between the Gal4 acidic domain and the
Tra1 protein (30). Tra1 is a member of the ATM superfamily,
and has been conserved during the evolution of eukaryotes,
and its mammalian homologue is TRRAP (transformation/
transcription domain-associated protein). TRRAP is common
to many HAT complexes and is required for their recruitment
to the chromatin during transcription, replication and DNA
repair (31). Thus, our data support a basic model in which
ZFY-long, but not ZFY-short, recruits TRRAP-containing
complexes to speciﬁc sites on meiotic chromosomes. ZFY-
short still maintains a large acidic domain of 183 amino acids
with a net charge of 232 that may recruit distinct complexes
to the chromatin during spermatogenesis.
Functional difference between Zfy1 and Zfy2 in MI
apoptotic response to X-univalence
We have recently established that Zfy1 and Zfy2 are function-
ally distinct in spermatocytes, since we have found that Zfy2,
but not Zfy1, is required for the efﬁcient apoptotic elimination
of MI spermatocytes with a univalent X chromosome (18). In
X
ESxr
bO mice, which express Zfy exclusively from the Zfy2/1
fusion gene, there is reduced MI apoptosis in response to the
unpaired X
ESxr
b chromosome. Since the Zfy2/1 fusion gene
has the promoter, 5′ UTR and ﬁrst coding exon from Zfy2,
the functional difference between Zfy1 and Zfy2 at MI
cannot be related to these parts of the genes. The functional
differences must, therefore, be related either to the coding
region (46 amino acid coding differences) or to the 3′ UTR.
Here, we have shown that, in spermatocytes, the Zfy2/1
fusion gene, the only Zfy gene in X
ESxr
bO mice, mainly pro-
duces transcripts lacking exon 6, like Zfy1. Furthermore, we
show that exon 6 encodes a segment of the acidic domain
that is required for at least a part of the transactivating activity
of ZFY1 and ZFY2. Thus, we establish that the absence of
exon 6 (183 amino acids) could underlie the functional differ-
ence between Zfy1 and Zfy2. We, therefore, hypothesize that
the potentiation of MI apoptosis in response to a univalent X
chromosome requires a ZFY protein with an acidic domain
Figure 8. The short acidic domains of ZFY do not transactivate in yeast cells.
(A) Levels of b-galactosidase induced by the Gal4-DNA-binding domain on
its own (pGBKT7—negative control) or fused to an acidic domain from S. cer-
evisiae (sc) GAL4-AD (positive control) or one of the six different ZFY iso-
forms (long or short) found in humans (hs) or mouse (mm). The four bars
for each construction on the y-axis represent the results of duplicate experi-
ments on two independent transformants (black or grey bars). b-Galactosidase
activity (x-axis) is expressed as the concentration of o-nitrophenol, measured
as OD420 units, generated from the substrate o-nitrophenol-b-D-galactoside per
minute per OD600 unit of yeast cells ×100.
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chromatin.
Zfy1 function
Several male mice that have an unpaired X chromosome, and
different combinations of Zfy1 and Zfy2, have been created
and studied. Comparisons of XSxr
aO( Zfy1 and Zfy2) and
X
EZ2O + Sry-tg (Zfy2 only), or X
EZ1/UO + Sry-tg (Zfy1 only)
and X
EO + Sry-tg (no Zfy gene), have not, however, revealed
any effect linked to the Zfy1 gene, during the ﬁrst meiotic pro-
phase (18). This raises the question of the role during meiosis
of Zfy1 speciﬁcally and of ZFY proteins with the short acidic
domain in general. In this regard, it is interesting to note
that, of the 46 amino acid differences between Zfy1 and
Zfy2, 34 are within the 363 amino acid acidic domain, and
only 4 map to the 372 amino acid zinc ﬁnger domain (exclud-
ing the Mus musculus-speciﬁc six amino acid deletion of the
third zinc ﬁnger in Zfy2). This indicates that the evolution of
both the Zfy1 and Zfy2 zinc ﬁnger domains has been con-
strained, implying that ZFY1 and ZFY2 may have the same
DNA targets, and that Zfy1 does have a selectable function.
Our ﬁnding of a ZFY transcript coding a short acidic domain
in humans is a good indication that the short isoform of
ZFY and consequently mouse Zfy1 do fulﬁl a conserved role
during spermatogenesis.
There is good evidence that the ZFY1 protein is translated
in early spermatocytes, as persistent transcription of Zfy1 in
spermatocytes after MSCI, from an autosomally located trans-
gene, causes a mid-pachytene block at stage IV (13). ZFY1
could have a subtle impact on spermatocyte development, im-
proving the efﬁciency or the ﬁdelity of the spermatogenic
process. Like ZFY2, ZFY1 could be involved in the regulation
of the apoptotic response at MI, perhaps acting to reduce apop-
tosis of normal XY spermatocytes by antagonizing ZFY2
binding to its target genes. An anti-apoptotic effect for
ZFY1 might be evident as increased MI apoptosis in the
absence of unsynapsed chromosomes, in male mice lacking
Zfy1, but expressing Zfy2.
Zfy1 and Zfy2 in the stage-IV spermatocyte block
The fact that the continued expression of either Zfy gene in
spermatocytes, during MSCI, results in a mid-pachytene
block (13) indicates that Zfy1 and Zfy2 could have the same
mode of action at this stage, despite their differing capacity
to promote apoptosis later at MI (18). This could be a conse-
quence of the highly similar zinc ﬁnger domains of ZFY1 and
ZFY2 proteins binding to the same promoter regions and redu-
cing access to other transcription factors. However, an alterna-
tive explanation is suggested by the fact that a proportion of
Zfy1 transcripts do code for the full-length acidic domain.
Our RT-qPCR data for Zfy1 and Zfy2 (Fig. 3C) indicate that,
during meiosis, transcripts with exon 6 are approximately
2-fold lower from Zfy1 than from Zfy2. However, the Zfy1-
transgenic animals, in which the stage-IV arrest was seen,
carried 14 copies of the Zfy1 transgene (13), and thus may
have produced a level of the full-length protein equivalent
to, or greater than, that produced by Zfy2, and it was this
that triggered the arrest. This explanation is consistent with
a model where it is only the ZFY protein with the full-length
acidic domain that promotes apoptosis in spermatocytes. The
importance of the full acidic domain to the known functions
of Zfy genes could be tested with transgenes engineered to
express Zfy1 with exon 6, and Zfy2 without exon 6.
The Zfy1/Zfy2 adaptation from the human perspective
Our data raise the possibility that, as regards Zfy function
during meiosis in the mouse, the important distinction may
not be between Zfy1 and Zfy2, but between full or partial
acidic domains. Seen in this way, humans and mice may be
understood to be using different means to achieve a similar ex-
pression of these two ZFY isoforms. Human ZFY expression
more closely resembles that of Zfy1 than that of Zfy2, in that
ZFY and Zfy1 are capable of producing transcripts with and
without the second coding exon in germ cells, whereas Zfy2
almost exclusively produces full-length transcripts. This
might be an indication that Zfy1 assures the core eutherian
ZFY functions, whereas Zfy2 has specialized in the elimination
of spermatocytes in which the X and the Y have failed to pair
through their PAR. Studies in the mouse have recently shown
that the reduced size of the PAR has been the selective force
for several adaptations, probably established before eutherian
radiation, to ensure double-strand break formation and
crossing-over in the PAR (32). The mouse PAR is 700 kb
(33), which is nearly four times shorter than the human PAR
(2.7 Mb) (34). The Zfy2 gene may, therefore, be an adaptation
selected for by the shortening of the PAR in the rodent lineage.
ZFY and human fertility
Our ﬁnding that human ZFY produces a transcript without the
equivalent of exon 6 that predominates in the testis and is
present in the testis that lack post-meiotic stages establishes
ZFY as a candidate gene for human male factor infertility.
Interestingly, like Zfy in the mouse, Usp9y is a testis-speciﬁc
gene whose transcription increases as germ cells begin to
enter meiosis in the testis (35). Furthermore, Zfy and Usp9y
are the only testis-speciﬁc mouse Y chromosome genes
whose human orthologues are widely expressed (36). Isolated
deletions of USP9Y (ﬁve cases) have only been found in the
male partners of couples consulting at infertility clinics, sug-
gesting that they do reduce male fertility (37–40). In three
cases, however, the USP9Y deletion has been transmitted nat-
urally, and the phenotype in most cases is mild; moderate oli-
gozoopermia in two cases (37), and normospermia in one case
(38), indicating that USP9Y increases the efﬁciency of sperm-
atogenesis without being essential for male fertility. ZFY
mutations could, therefore, have similar slight effects on
male fertility.
To begin to evaluate the extent to which mutations in ZFY
are a cause of human male fertility, we have screened 520 in-
fertile men for the deletion of the ZFY gene, using PCR tests
for the two ends and the middle of the gene, but have failed to
ﬁnd any deletions (M.J.M. and E.S., unpublished data). The
incidence of large deletions affecting ZFY is, therefore, low
(, 0.2%) in our infertile population. Nevertheless, it is now
established that, in the mouse, ZFY2 contributes to the strin-
gency of the pairing checkpoint at MI (18), and ZFY might
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case, it will be important to identify those rare men with a mu-
tation in ZFY, as this could have consequences for the stable
transmission of the genome to the next generation.
MATERIALS AND METHODS
Mouse samples
Staged testes (day of birth ¼ 0 d.p.p.) were from: (i) XY




distally to the Y PAR, together with their XY littermates
(Random-bred MF1 stock background—NIMR colony) and
(iii) X
ESxr
bO males that carry an Eif2s3y transgene inserted
on the X chromosome and Sxr
b attached distally to the X
PAR (also on an MF1 background). The production of the
X
ESxr
bO males has been described elsewhere (18).
Patient samples: maturation arrest biopsies
Testicular samples were obtained from two azoospermic
patients who underwent a testicular biopsy in order to
recover testicular spermatozoa within the context of an intra-
cytoplasmic sperm injection (ICSI) attempt. Each patient had
a normal karyotype. Patient Ste-363 from St Etienne has a
P5/proximal-P1 deletion of the AZFb interval of the Y
chromosome and has been described previously (41). Patient
APOP12, from Marseille, has no detectable Y chromosome
deletion. He gave his informed consent for the storage of the
immature testicular cells in our ‘Germetheque’ biobank, and
their use in research. A meiotic study performed on cells
from Apop12 revealed an early meiotic block, with 97% of
spermatocytes at the leptotene stage (C.M.-G., unpublished
data). In both cases, the material was the remains of a testicu-
lar biopsy after it had been teased apart to recover spermato-
zoa for ICSI.
Patient samples: sperm
Human ejaculates were collected by masturbation from normal
men, consulting with their partner for couple infertility,
through the Sperm Diagnostic Unit, Biology of Reproduction
Laboratory, La Conception Hospital, Marseilles, France. Men
participating in this study consulted for a sperm analysis as
part of the exploration of the infertility of their couple, and
gave informed consent that the remaining part of the semen
sample could be stored and used in research instead of being
discarded. Samples were included in the ‘Germetheque’
biobank. Sperm analysis was performed according to the
WHO criteria and morphology was assessed according to
the French DAVID classiﬁcation (Table 1). After sperm ana-
lysis, the remaining sperm was centrifuged at 3000 r.p.m. for
15 min. The pellet was frozen and stored in liquid nitrogen
until use.
RNA extraction
For all mouse samples, polyA
+ RNA was isolated using the
mMACs mRNA Isolation Kit (Miltenyi Biotec) according to
the manufacturer’s protocol. For human testis biopsies, total
RNA was extracted with TriPure (Roche), as previously
described (41). Total human RNAs from normal human
testes and other tissues were purchased from Clontech. To
extract RNA from spermatozoa, pelleted samples were
thawed and washed twice in 2 ml of PBS. They were then
resuspended in round cell lysis buffer (0.1% SDS, 0.5%
Triton X-100 in RNase-free H2O) for 10 min on ice and
then washed twice in PBS. This treatment preferentially
lyses somatic cells and immature germ cells while leaving
spermatozoa intact (42). RNAs were extracted from 15 ×
10
6 spermatozoa with 1 ml of TriPure (Roche) following the
manufacturer’s protocol. RNA was precipitated twice with iso-
propanol in the presence of 20 mg of glycogen (Roche). The
RNA was subsequently treated with DNase I and RNase-free
(Roche) and then either puriﬁed by passage through a
Chroma Spin-200 + DEPC-H2O column (Clontech) (samples
08153 and 09203) or by isopropanol precipitation (sample
09175).
PCR, RT-PCR and 3′ RACE
For the mouse, in general, 500 ng of mRNA were converted
into cDNA with expand RT (Roche) and random nonamers
in a 20 ml reaction volume. Less mRNA was used for the
X
ESxr
bO cDNAs, because RNA was extracted from testis
fragments and yields were ,500 ng, but in all these cases,
the corresponding XY control cDNA was generated from an
equivalent amount of RNA. Mouse cDNAs were diluted
10-fold and 1 ml, or a volume corresponding to 2.5 ng of
input mRNA, used in a ﬁnal PCR volume of 12 ml. PCR
was performed using standard protocols.
For 3′ RACE, cDNAs were synthesized using an oligo-
dT-adaptor primer (GACTCGAGTCGACATCGA-dT17).
RACE PCR was performed as nested PCR with a single
reverse adaptor primer (o2761) and two forward primers spe-
ciﬁc for Zfy1 (o2828 then o2851) or Zfy2 (o2827 then o2852).
The ﬁrst PCR was for 30 cycles and then 1 ml was used for a
second PCR of 30 cycles.
Table 1. The semen characteristics of the three samples used for our study, compared with normospermic parameters (last line)








08153 2.3 40 (8.3) 20 (0/20/20/60) 19 Astheno-teratospermia
09203 6.2 89 (1.4) 65 (45/20/5/30) 27 Mild teratospermia
09175 3.5 364 (15.6) 40 (5/35/30/30) 51 Asthenospermia
— .2 .20 .50 or a is .25 .30 Normospermia
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converted to cDNA in a 20 ml reaction, diluted 10-fold and
1 ml used for PCR in a 12 ml reaction. For spermatozoal
RNA, all recovered total RNA was converted to cDNA,
diluted 2-fold and 1 ml used in a 12 ml PCR reaction. RT reac-
tions were random-primed.
All primers used are listed in Supplementary Material,
Table S1.
Sequencing
Individual PCR products were cut from agarose gels and puri-
ﬁed using NucleoSpin Extract II (Macherey-Nagel) according
to the manufacturer’s protocol, and sequenced using BigDye
Terminator v1.1 Cycle Sequencing Kit (Applied Biosystems).
Sequences were then analysed with the Sequencher 4.2 soft-
ware (Genecodes). Comparisons were made with sequences
deposited in the NCBI database: mouse Zfy1 (NM009570),
Zfy2 from its Cypt (AK133222) or its Zfy promoter
(AK030048) and human ZFY (NM003411).
Quantitative real-time reverse transcription PCR
Quantitative RT-PCR was performed with the LightCycler
480 SYBR Green I Master Kit (Roche) on the LightCycler
480 (Roche). Reactions were performed in 10 ml. Ampliﬁca-
tion conditions were 1 cycle at 958C for 5 min, followed by
43 cycles of 958C for 10 s, 58 or 608C for 15 s, 728Cf o r
15 s. Controls with H2O were negative for all tests. All reac-
tions were carried out in triplicate per assay and Hmbs was
included on every plate as a loading control. The melting
curve proﬁles were analysed for every sample to verify the
absence of non-speciﬁc products or primer dimers.
For each sample, the mean Ct for Hmbs was subtracted from
themean CtforZfy(DCt).Thevalue forthe Zfytranscript level
was calculated from this DCt by attributing the arbitrary value
of 1000 to the Hmbs transcript level, using the formula
E
DCt × 1000, where E is the PCR efﬁciency. E was calculated
for each primer pair, using a series of dilutions of template
cDNA. The slope (a) of the standard curve, Ct ¼ a(log
[conc])+b, was obtained by plotting log10 cDNA concentra-
tion, [conc], against Ct, and E was calculated as 10
(21/a). For
each plot, R
2 was .0.99. If a reaction has 100% efﬁciency,
E ¼ 2. Values for E ranged from 1.88 to 2 (Supplementary
Material, Table S1).
We chose the Hmbs gene as control housekeeping gene
because it showed low variability in Ct between all testis
stages when equivalent quantities of cDNA were used as tem-
plate.
RNA FISH
RNA FISH was performed as previously described (12,20).
Wild-type testis material was from adult MF1 male mice. To
provide control material to monitor probe speciﬁcity, we
used 30 d.p.p. testes from X
EZ1/UOSry or X
EZ2OSry transgenic
males; these males carry BAC transgenes for Eif2s3y (
E) to-
gether with a BAC transgene for Zfy1 + Ube1y (
Z1/U)o r
Zfy2 (
Z2), on their single X chromosome, with testis develop-
ment driven by an autosomally located Sry transgene (13,18).
The Zfy2-speciﬁc probe used was the BAC CITB-288D7 (Re-
search Genetics). The Zfy1-speciﬁc probe used was a modiﬁed
version of BAC RP24-498K8 (CHORI) from which we had
removed the entire Ube1y gene by recombineering.
ZFY-Gal4 fusion proteins
ZFY-Gal4 fusion-protein constructs were made by inserting
PCR-ampliﬁed cDNA segments encoding the different acidic
domains into the NcoI and SalI restriction sites of pGBKT7
(Clontech), downstream of the GAL4 DNA-binding domain
and the c-myc epitope tag of the vector. Long and short
acidic domains were ampliﬁed together for each ZFY gene
from testis cDNA, and each fragment was puriﬁed following
size fractionation on an agarose gel. The GAL4 acidic
domain (GAL4-AD) was integrated into pGBKT7 as a positive
control and was ampliﬁed from the vector pGADT7 (Clon-
tech). Primers used, with respectively an NcoIo rSalI
adaptor, were ZFY: o4108/o4109, Zfy1: o4100/o4101, Zfy2:
o4102/o4103 and GAL4-AD: o4106/o4107 (Supplementary
Material, Table S1). Recombinants were veriﬁed by sequen-
cing the entire PCR product and vector ﬂanks. Two recombi-
nants were selected for each construct and transformed into
cells from the S. cerevisiae strain Y187, in which the
b-galactosidase gene is under the control of the Gal4-
responsive GAL1 promoter. Single-transformed colonies were
picked from SD/-trp agar plates and grown in liquid culture
to an OD600 of 0.6–1.2 in SD/-trp liquid minimal medium.
The b-galactosidase assay was performed on  1O D 600 unit
of the culture, using the permeabilized cell assay (43).
Another 2.5 OD600 units from the same culture were used to
prepare protein for standard western blot analysis using an anti-
human c-myc tag antibody (Biolegend) (Supplementary Mater-
ial, Fig. S1).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
ACKNOWLEDGEMENTS
We are very grateful to the men who consented to their biopsy
material or sperm sample being used for our research. We
thank the Reproductive Biology Service at the Ho ˆpital de La
Conception for their invaluable help in collecting the human
material and, in particular, Professor Jean-Marie Grillo
(Service Head), Professor Marie Guichaoua and the technical
staff, Cathy Metton and Marie-Jose ´e Fays-Bernardin. Thanks
also to Fre ´de ´rique Lembo and Jean-Paul Borg of the Marseille
Cancerology Research Centre (CRCM) for helping us set up
the transactivation assay in yeast. P.S.B. is indebted to MRC
NIMR Procedural Service Section for the production of GA
lines and to Biological Services for animal husbandry and
technical support. Thanks also to Helen Skaletsky and Jennifer
Alfoldi for kindly sending us the RP24-498K8 BAC clone.
Conﬂict of Interest statement. None declared.
Human Molecular Genetics, 2012, Vol. 21, No. 12 2643FUNDING
This work was supported by core funding from the Institut na-
tional de la sante ´ et de la recherche ´m e ´dicale (Inserm) to
M.J.M.; an Inserm-Re ´gion Provences-Alpes-Co ˆtes d’Azur
doctoral fellowship to F.D.; a French Ministry of Research
and Technology doctoral fellowship to E.S.; the Medical Re-
search Council UK (U117532009 to P.S.B., and MRC CDF
to N.V.) and an EMBO fellowship to N.V. Funding to pay
the Open Access publication charges for this article was pro-
vided by the UK Medical Research Council.
REFERENCES
1. Page, D.C., Mosher, R., Simpson, E.M., Fisher, E.M.C., Mardon, G.,
Pollack, J., McGillivray, B., de la Chapelle, A. and Brown, L.G. (1987)
The sex-determining region of the human Y chromosome encodes a ﬁnger
protein. Cell, 51, 1091–1104.
2. Galan-Caridad, J.M., Harel, S., Arenzana, T.L., Hou, Z.E., Doetsch, F.K.,
Mirny, L.A. and Reizis, B. (2007) Zfx controls the self-renewal of
embryonic and hematopoietic stem cells. Cell, 129, 345–357.
3. Sinclair, A.H., Foster, J., Spencer, J., Page, D., Palmer, M., Goodfellow,
P. and Graves, J. (1988) Sequences homologous to ZFY, a candidate
human sex-determining gene are autosomal in marsupials. Nature, 336,
780–783.
4. Graves, J. (1995) The origin and function of the mammalian Y
chromosome and Y-borne genes – an evolving understanding. Bioessays,
17, 311–321.
5. Mardon, G., Luoh, S.-W., Simpson, E., Gill, G., Brown, L. and Page, D.
(1990) Mouse Zfx protein is similar to Zfy-2: each contains an acidic
domain and 13 zinc ﬁngers. Mol. Cell. Biol., 10, 681–688.
6. Schneider-Ga ¨dicke, A., Beer-Romero, P., Brown, L.G., Nussbaum, R. and
Page, D.C. (1989) ZFX has a gene structure similar to ZFY, the putative
human sex determinant, and escapes X inactivation. Cell, 57, 1247–1258.
7. Koopman, P., Gubbay, J., Collignon, J. and Lovell-Badge, R. (1989) Zfy
gene expression patterns are not compatible with a primary role in mouse
sex determination. Nature, 342, 940–942.
8. Mardon, G., Mosher, R., Disteche, C.M., Nishioka, Y., McLaren, A. and
Page, D.C. (1989) Duplication, deletion and polymorphism in the
sex-determining region of the mouse Y chromosome. Science, 243,7 8 –
80.
9. Nagamine, C.M., Chan, K., Hake, L.E. and Lau, Y.F. (1990) The two
candidate testis-determining Y genes (Zfy-1 and Zfy-2) are differentially
expressed in fetal and adult mouse tissues. Genes Dev., 4, 63–74.
10. Nagamine, C.M., Chan, K., Kozak, C.A. and Lau, Y.-F. (1989)
Chromosome mapping and expression of a putative testis-determining
gene in mouse. Science, 243, 80–83.
11. Hansen, M.A., Nielsen, J.E., Tanaka, M., Almstrup, K., Skakkebaek, N.E.
and Leffers, H. (2006) Identiﬁcation and expression proﬁling of 10 novel
spermatid expressed CYPT genes. Mol. Reprod. Dev., 73, 568–579.
12. Mahadevaiah, S.K., Bourc’his, D., de Rooij, D.G., Bestor, T.H., Turner,
J.M. and Burgoyne, P.S. (2008) Extensive meiotic asynapsis in mice
antagonises meiotic silencing of unsynapsed chromatin and consequently
disrupts meiotic sex chromosome inactivation. J. Cell Biol., 182, 263–
276.
13. Royo, H., Polikiewicz, G., Mahadevaiah, S.K., Prosser, H., Mitchell, M.,
Bradley, A., de Rooij, D.G., Burgoyne, P.S. and Turner, J.M. (2010)
Evidence that meiotic sex chromosome inactivation is essential for male
fertility. Curr. Biol., 20, 2117–2123.
14. Turner, J.M. (2007) Meiotic sex chromosome inactivation. Development,
134, 1823–1831.
15. Kitamura, K., Iguchi, N., Kaneko, Y., Tanaka, H. and Nishimune, Y.
(2004) Characterization of a novel postacrosomal perinuclear
theca-speciﬁc protein, CYPT1. Biol. Reprod., 71, 1927–1935.
16. Cattanach, B.M., Pollard, C.E. and Hawkes, S.G. (1971) Sex-reversed
mice: XX and XO males. Cytogenetics, 10, 318–337.
17. Simpson, E.M. and Page, D.C. (1991) An interstitial deletion in mouse Y
chromosomal DNA created a transcribed Zfy fusion gene. Genomics, 11,
601–608.
18. Vernet, N., Mahadevaiah, S.K., Ojarikre, O.A., Longepied, G., Prosser,
H.M., Bradley, A., Mitchell, M.J. and Burgoyne, P.S. (2011) The
Y-encoded gene Zfy2 acts to remove cells with unpaired chromosomes at
the ﬁrst meiotic metaphase in male mice. Curr. Biol., 21, 787–793.
19. Page, D.C., Fisher, E.M., McGillivray, B. and Brown, L.G. (1990)
Additional deletion in sex-determining region of human Y chromosome
resolves paradox of X,t(Y;22) female. Nature, 346, 279–281.
20. Mahadevaiah, S.K., Costa, Y. and Turner, J.M. (2009) Using RNA FISH
to study gene expression during mammalian meiosis. Methods Mol. Biol.,
558, 433–444.
21. Mahaffey, C.L., Bayleran, J.K., Yeh, G.Y., Lee, T.C., Page, D.C. and
Simpson, E.M. (1997) Intron/exon structure conﬁrms that mouse Zfy1 and
Zfy2 are members of the ZFY gene family. Genomics, 41, 123–127.
22. Zambrowicz, B.P., Findley, S.D., Simpson, E.M., Page, D.C. and
Palmiter, R.D. (1994) Characterization of the murine Zfy1 and Zfy2
promoters. Genomics, 24, 406–408.
23. North, M., Sargent, C., O’Brien, J., Taylor, K., Wolfe, J., Affara, N.A. and
Ferguson-Smith, M.A. (1991) Comparison of ZFY and ZFX gene
structure and analysis of alternative 3′ untranslated regions of ZFY.
Nucleic Acids Res., 19, 2579–2586.
24. Mazeyrat, S., Saut, N., Grigoriev, V., Mahadevaiah, S.K., Ojarikre, O.A.,
Rattigan, A., Bishop, C., Eicher, E.M., Mitchell, M.J. and Burgoyne, P.S.
(2001) A Y-encoded subunit of the translation initiation factor Eif2 is
essential for mouse spermatogenesis. Nat. Genet., 29, 49–53.
25. Ostermeier, G.C., Dix, D.J., Miller, D., Khatri, P. and Krawetz, S.A.
(2002) Spermatozoal RNA proﬁles of normal fertile men. Lancet, 360,
772–777.
26. Zambrowicz, B.P., Zimmermann, J.W., Harendza, C.J., Simpson, E.M.,
Page, D.C., Brinster, R.L. and Palmiter, R.D. (1994) Expression of a
mouse Zfy-1/lacZ transgene in the somatic cells of the embryonic gonad
and germ cells of the adult testis. Development, 120, 1549–1559.
27. Berta, P., Hawkins, J.R., Sinclair, A.H., Taylor, A., Grifﬁths, B.L.,
Goodfellow, P.N. and Fellous, M. (1990) Genetic evidence equating SRY
and the testis-determining factor. Nature, 348, 448–450.
28. Koopman, P., Gubbay, J., Vivian, N., Goodfellow, P. and Lovell-Badge, R.
(1991) Male development of chromosomally female mice transgenic for
Sry. Nature, 351, 117–121.
29. Ashworth, A., Skene, B., Swift, S. and Lovell-Badge, R. (1990) Zfa is an
expressed retroposon derived from an alternative transcript of the Zfx
gene. EMBO J, 9, 1529–1534.
30. Traven, A., Jelicic, B. and Sopta, M. (2006) Yeast Gal4: a transcriptional
paradigm revisited. EMBO Rep., 7, 496–499.
31. Murr, R., Vaissiere, T., Sawan, C., Shukla, V. and Herceg, Z. (2007)
Orchestration of chromatin-based processes: mind the TRRAP. Oncogene,
26, 5358–5372.
32. Kauppi, L., Barchi, M., Baudat, F., Romanienko, P.J., Keeney, S. and
Jasin, M. (2011) Distinct properties of the XY pseudoautosomal region
crucial for male meiosis. Science, 331, 916–920.
33. Perry, J., Palmer, S., Gabriel, A. and Ashworth, A. (2001) A short
pseudoautosomal region in laboratory mice. Genome Res., 11, 1826–
1832.
34. Blaschke, R.J. and Rappold, G. (2006) The pseudoautosomal regions,
SHOX and disease. Curr. Opin. Genet. Dev., 16, 233–239.
35. Brown, G.M., Furlong, R.A., Sargent, C.A., Erickson, R.P., Longepied, G.,
Mitchell, M., Jones, M.H., Hargreave, T.B., Cooke, H.J. and Affara, N.A.
(1998) Characterisation of the coding sequence and ﬁne mapping of the
human DFFRY gene and comparative expression analysis and mapping to
theSxrbintervalofthemouseY chromosomeof theDffrygene.Hum.Mol.
Genet., 7, 97–107.
36. Mazeyrat, S., Saut, N., Sargent, C., Grimmond, S., Longepied, G.,
Ehrmann, I., Ellis, P., Greenﬁeld, A., Affara, N. and Mitchell, M. (1998)
The mouse Y chromosome interval necessary for spermatogonial
proliferation is gene dense with syntenic homology to the human AZFa
region. Hum. Mol. Genet., 7, 1713–1724.
37. Krausz,C.,Degl’innocenti,S.,Nuti,F.,Morelli,A.,Felici,F.,Sansone,M.,
Varriale, G. and Forti, G. (2006) Natural transmission of USP9Y gene
mutations: a new perspective on the role of AZFa genes in male fertility.
Hum. Mol. Genet., 15, 2673–2681.
38. Luddi,A.,Margollicci,M.,Gambera,L.,Seraﬁni,F.,Cioni,M.,DeLeo,V.,
Balestri, P. and Piomboni, P. (2009) Spermatogenesis in a man with
complete deletion of USP9Y. N. Engl. J. Med., 360, 881–885.
39. Sargent,C.A.,Boucher,C.A.,Kirsch,S.,Brown,G.,Weiss,B.,Trundley,A.,
Burgoyne,P.,Saut,N.,Durand,C.,Levy,N.etal.(1999)Thecritical region
2644 Human Molecular Genetics, 2012, Vol. 21, No. 12ofoverlapdeﬁningtheAZFamaleinfertilityintervalofproximalYqcontains
three transcribed sequences. J. Med. Genet., 36, 670–677.
40. Sun, C., Skaletsky, H., Birren, B., Devon, K., Tang, Z., Silber, S., Oates,
R. and Page, D.C. (1999) An azoospermic man with a de novo point
mutation in the Y-chromosomal gene USP9Y. Nat. Genet., 23, 429–432.
41. Longepied, G., Saut, N., Aknin-Seifer, I., Levy, R., Frances, A.M.,
Metzler-Guillemain, C., Guichaoua, M.R. and Mitchell, M.J. (2010)
Complete deletion of the AZFb interval from the Y chromosome in an
oligozoospermic man. Hum. Reprod., 25, 2655–2663.
42. Platts, A.E., Dix, D.J., Chemes, H.E., Thompson, K.E., Goodrich, R.,
Rockett, J.C., Rawe, V.Y., Quintana, S., Diamond, M.P., Strader, L.F.
et al. (2007) Success and failure in human spermatogenesis as revealed by
teratozoospermic RNAs. Hum. Mol. Genet., 16, 763–773.
43. Guarente, L. (1983) Yeast promoters and lacZ fusions designed to study
expression of cloned genes in yeast. Methods Enzymol., 101, 181–191.
44. Reynard, L.N. and Turner, J.M. (2009) Increased sex chromosome
expression and epigenetic abnormalities in spermatids from male mice
with Y chromosome deletions. J. Cell Sci., 122, 4239–4248.
Human Molecular Genetics, 2012, Vol. 21, No. 12 2645